Trial of Anifrolumab in Active Systemic Lupus Erythematosus von Morand, Eric F, Furie, Richard, Tanaka, Yoshiya, Bruce, Ian N, Askanase, Anca D, Richez, Christophe, Bae, Sang-Cheol, Brohawn, Philip Z, Pineda, Lilia, Berglind, Anna, Tummala, Raj

Volltext

32 Optimising lupus drug trial designs von Morand, Eric

Volltext

06 Approved biologics for SLE: which to try first and in which patients? – The case for anifrolumab von Morand, Eric

Volltext

It hasn't gone away: the problem of glucocorticoid use in lupus remains von Apostolopoulos, Diane, Morand, Eric F

Volltext

Definition and initial validation of a Lupus Low Disease Activity State (LLDAS) von Franklyn, Kate, Lau, Chak Sing, Navarra, Sandra V, Louthrenoo, Worawit, Lateef, Aisha, Hamijoyo, Laniyati, Wahono, C Singgih, Chen, Shun Le, Jin, Ou, Morton, Susan, Hoi, Alberta, Huq, Molla, Nikpour, Mandana, Morand, Eric F

Volltext

05 LLDAS is an excellent outcome measure, but does it really capture patients with true LDA? von Morand, Eric

Volltext

Antidrug antibodies (ADAb) to tumour necrosis factor (TNF)-specific neutralising agents in chronic inflammatory diseases: a real issue, a clinical perspective von Vincent, Fabien B, Morand, Eric F, Murphy, Kim, Mackay, Fabienne, Mariette, Xavier, Marcelli, Christian

Volltext

Easy-BILAG: as easy as ABC? von Connelly, Kathryn, Morand, Eric F

Volltext

Clinical associations of serum interleukin-17 in systemic lupus erythematosus von Vincent, Fabien B, Northcott, Melissa, Hoi, Alberta, Mackay, Fabienne, Morand, Eric F

Volltext

Systemic lupus erythematosus: Stress and the onset of SLE von Morand, Eric F

Volltext

Filgotinib in cutaneous lupus: is a negative positive? von Connelly, Kathryn, Morand, Eric F

Volltext

06 Interferon inhibition and the future management of SLE von Morand, Eric

Volltext

Targeting Interferon Signalling in Systemic Lupus Erythematosus: Lessons Learned von Jones, Sarah A., Morand, Eric F.

Volltext

Clinical associations of IL-10 and IL-37 in systemic lupus erythematosus von Godsell, Jack, Rudloff, Ina, Kandane-Rathnayake, Rangi, Hoi, Alberta, Nold, Marcel F., Morand, Eric F., Harris, James

Volltext

Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus von He, Jing, Zhang, Xia, Wei, Yunbo, Sun, Xiaolin, Chen, Yaping, Deng, Jun, Jin, Yuebo, Gan, Yuzhou, Hu, Xin, Jia, Rulin, Xu, Chuanhui, Hou, Zhaohua, Leong, Yew Ann, Zhu, Lei, Feng, Jinhong, An, Yuan, Jia, Yuan, Li, Chun, Liu, Xu, Ye, Hua, Ren, Limin, Li, Ru, Yao, Haihong, Li, Yuhui, Chen, Shi, Zhang, Xuewu, Su, Yin, Guo, Jianping, Shen, Nan, Morand, Eric F, Yu, Di, Li, Zhanguo

Volltext

Genetic contributions to lupus nephritis in a multi-ethnic cohort of systemic lupus erythematous patients von Lanata, Cristina M, Nititham, Joanne, Taylor, Kimberly E, Chung, Sharon A, Torgerson, Dara G, Seldin, Michael F, Pons-Estel, Bernardo A, Tusié-Luna, Teresa, Tsao, Betty P, Morand, Eric F, Alarcón-Riquelme, Marta E, Criswell, Lindsey A

Volltext

Macrophage migration inhibitory factor is required for NLRP3 inflammasome activation von Lang, Tali, Lee, Jacinta P. W., Elgass, Kirstin, Pinar, Anita A., Tate, Michelle D., Aitken, Elizabeth H., Fan, Huapeng, Creed, Sarah J., Deen, Nadia S., Traore, Daouda A. K., Mueller, Ivo, Stanisic, Danielle, Baiwog, Francesca S., Skene, Colin, Wilce, Matthew C. J., Mansell, Ashley, Morand, Eric F., Harris, James

Volltext

Systemic lupus erythematosus: a clinical update von Connelly, Kathryn, Morand, Eric F.

Volltext

Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-II) von Petri, Michelle, Bruce, Ian N, Dörner, Thomas, Tanaka, Yoshiya, Morand, Eric F, Kalunian, Kenneth C, Cardiel, Mario H, Silk, Maria E, Dickson, Christina L, Meszaros, Gabriella, Zhang, Lu, Jia, Bochao, Zhao, Youna, McVeigh, Conor J, Mosca, Marta

Volltext

Measurement of specific organ domains in lupus randomized controlled trials: a scoping review von Connelly, Kathryn, Vettivel, Jeevan, Golder, Vera, Kandane-Rathnayake, Rangi, Morand, Eric F

Volltext